Anti-CD-X CAR-T cell therapy (Antion Biosciences)

N/A

Report date: 2024/08/01 17:14:08

Base Information

Drug NameAnti-CD-X CAR-T cell therapy (Antion Biosciences)
Drug Alias NameAnti CDX chimeric antigen receptor T cell therapy (Antion Biosciences)Allogeneic miCARX T-cells (Antion Biosciences)anti-CDX CAR T-cells (Antion Biosciences)miCAR-X (Antion Biosciences)
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAntion Biosciences SA
China Registration ClassN/A

Develop Information

Active CompaniesAntion Biosciences SA
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A